Tag: #Global Trends

Shares in Novo Nordisk plummeted on February 4, 2026, following a sobering outlook for the coming year. The Danish pharmaceutical... Read more

On February 4, 2026, California-based Eikon Therapeutics successfully raised $381 million in its initial public offering (IPO), marking the third... Read more

Despite facing nearly $16 billion in U.S. revenue erosion for its long-time blockbuster Humira, AbbVie reported a record-breaking $61.1 billion... Read more

On February 2, 2026, SanegeneBio and Genentech (part of the Roche Group) announced a global licensing agreement to advance an... Read more

The Prescription Medicines Code of Practice Authority (PMCPA) in the UK has sanctioned Sanofi following controversial remarks made by its... Read more

AstraZeneca’s application for a subcutaneous (SC) version of its lupus therapy, Saphnelo, has been rejected by the U.S. Food and... Read more

The push into biologics addresses rising domestic rates of diabetes and cancer while pursuing broader economic objectives: Reducing Import Dependency:... Read more

The Ontario Court of Justice has issued a 750,000 CAD fine (approximately 14 billion VND) against the Estée Lauder group... Read more

Pharmaceutical giant Eli Lilly has unveiled plans to construct a major production facility for injectable medicines and delivery devices in... Read more